1-(Pyridin-3-yl)cyclopropan-1-amine bis(4-nitrobenzoate), 98%, 1g

7-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine, 95.0%, 10g

tert-Butyl 4-oxoazepane-1-carboxylate, 98.0%, 1g

3-(Chloromethyl)pyridine Hydrochloride>98.0%(HPLC)(T)100g

2,3-Difluoro-4-methoxybenzyl alcohol, 250mg

H-DL-Pro-OH, 98%, 100g

Lithium carbonate, min. 99%, ultra pure, 100 g, plastic packaging.

(E)-4,4'-(Diazene-1,2-diyl)bis(2-methylbenzoic acid), 98%, 100mg

2-Propan-2-yladamantan-2-ol, 97%, 5g

5-Ethoxy-6-methylpyridin-2-amine, 95.0%, 1g

GC capillary column ROTI®Cap-1, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)

6-Chlorobenzo[d]oxazol-2(3H)-one, 95.0%, 500g

Tris(1,10-phenanthroline)cobalt(III) Tris(hexafluorophosphate)>97.0%(T)1g